Scribd Logo
Upload

Welcome to Scribd!

  • 32 views

    Managing MNC Drug Short: Prepared By: A001 Rashmi Quamar A003 Anoushka Das A025 Vishal Sharma A036 Anand Praveen

    Uploaded by

    Vishal
    This document contains an agenda for discussing issues related to drug price gouging by pharmaceutical companies. The agenda includes: 1) areas where criminal action could have been taken against Valeant/Mike Pearson/Bill Ackman and if any action was taken; 2) why pharma companies are allowed to raise drug prices and actions from Hillary Clinton's promise on the issue; 3) regulatory and ethical recommendations to prevent future issues; and 4) what prevents similar issues in India.

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd

    Managing MNC Drug Short: Prepared By: A001 Rashmi Quamar A003 Anoushka Das A025 Vishal Sharma A036 Anand Praveen

    Uploaded by

    Vishal
    32 views7 pages
    This document contains an agenda for discussing issues related to drug price gouging by pharmaceutical companies. The agenda includes: 1) areas where criminal action could have been taken against Valeant/Mike Pearson/Bill Ackman and if any action was taken; 2) why pharma companies are allowed to raise drug prices and actions from Hillary Clinton's promise on the issue; 3) regulatory and ethical recommendations to prevent future issues; and 4) what prevents similar issues in India.

    Original Title

    Mnc

    Copyright

    © © All Rights Reserved

    Available Formats

    PPTX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    This document contains an agenda for discussing issues related to drug price gouging by pharmaceutical companies. The agenda includes: 1) areas where criminal action could have been taken against Valeant/Mike Pearson/Bill Ackman and if any action was taken; 2) why pharma companies are allowed to raise drug prices and actions from Hillary Clinton's promise on the issue; 3) regulatory and ethical recommendations to prevent future issues; and 4) what prevents similar issues in India.

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Download as pptx, pdf, or txt
    32 views7 pages

    Managing MNC Drug Short: Prepared By: A001 Rashmi Quamar A003 Anoushka Das A025 Vishal Sharma A036 Anand Praveen

    Uploaded by

    Vishal
    This document contains an agenda for discussing issues related to drug price gouging by pharmaceutical companies. The agenda includes: 1) areas where criminal action could have been taken against Valeant/Mike Pearson/Bill Ackman and if any action was taken; 2) why pharma companies are allowed to raise drug prices and actions from Hillary Clinton's promise on the issue; 3) regulatory and ethical recommendations to prevent future issues; and 4) what prevents similar issues in India.

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Download as pptx, pdf, or txt
    of 7

    Managing MNC

    Drug Short
    Prepared By:
    A001 Rashmi Quamar
    A003 Anoushka Das
    A025 Vishal Sharma
    A036 Anand Praveen
    Agenda

    01. What are the areas where criminal action could have been taken against
    Valeant/Mike Pearson/ Bill Ackman? Was any action taken ? Why?
    2. Why are pharma companies allowed to do price gouging? What actions resulted
    from Hilary Clinton's promise to the public?
    3. What regulatory and ethical norms would you recommend putting in place to avoid
    future catastrophies of this nature?
    4. What prevents something like this from happening in India?

    2
    What are the areas where criminal action could have been
    taken against Valeant/Mike Pearson/ Bill Ackman? Was any
    action taken ? Why?

    • Accounting Practices and Misstated


    Valeant & Mike Financial Reports
    Pearson • Securities Fraud
    • Aggressive Manipulation of Drug Prices

    Bill Ackman • Allergan - Insider Trading


    Why are pharma companies allowed to do price gouging?
    What actions resulted from Hilary Clinton's promise to the
    public?
    What regulatory and ethical norms would you
    recommend putting in place to avoid future
    catastrophies of this nature?
    Ban Direct to Consumer Marketing

    Eliminate pay-to-delay payments

    Pass the Creating And Restoring Equal Access To


    Equivalent Samples Act Act of 2016

    Allow drug imports when companies egregiously raise


    prices

    Eliminate patient assistance co-pay cards


    What prevents something like this from happening in India?

    DPCO 2013 DPCO 2013


    Price
    Fixation
    Price Revision
    Upwards
    Price Revision
    Downwards
    Compare MRP
    Compare WPI to
    Taxes to WPI
    Scheduled Compare with existing price and
    with CP and
    NPPA Formulations ceiling price CP (lower of the
    two)
    reduce only if at
    CP
    Up to 10% at the
    Non-Scheduled Any price end of 12 months
    NLEM 2021 Formulations deemed fit from last price
    revision
    No restrictions

    Up to 10% at the
    Follow retail
    end of 12 months
    New Drugs price for first No restrictions
    Competition Act, 2002 year
    from last price
    revision
    Based on Based on
    Only if approved
    Para 19 Retail/CP Retail/CP
    by NPPA
    Indian Patents Act, 1970 Section notification notification

    84 (1)
    Thank you

    Group 9
    Division - A

    You might also like